Newsroom

Categories: Corporate, Finance & Investor, Clinical Diagnostics, biopharma

Leica Biosystems and CellCarta expand collaborative companion diagnostic development model to accelerate commercialization globally

June 1, 2026

Categories: Diagnostics & Hospital Laboratory, Drug Discovery & Development, Pharma, Clinical Research & Trials, Clinical Diagnostics

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

May 27, 2026

Categories: Biomanufacturing, Corporate, Finance & Investor, Clinical Diagnostics

Medix Biochemica announces $5 million investment to expand recombinant antigen capabilities

May 18, 2026

Categories: Corporate, Finance & Investor, Clinical Diagnostics

Medix Biochemica appoints Petra Furu as Chief Executive Officer

April 15, 2026

Categories: Clinical Research & Trials, Clinical Diagnostics

CellCarta and Pillar Biosciences announce multi-year global strategic partnership to expand rapid, decentralized tumor profiling for oncology clinical trials

April 2, 2026

Categories: Biotechnology, Corporate, Finance & Investor, Clinical Diagnostics

EazeBio and UC Santa Cruz announce strategic partnership to advance instrument-free diagnostic platform

October 29, 2025

Categories: Biotechnology, Drug Discovery & Development, Pharma, Clinical Diagnostics

Aptamer Group introduces novel biomarker discovery service

August 28, 2025

Categories: Pharma, Corporate, Finance & Investor, Clinical Diagnostics

Medix Biochemica expands its offering of critical IVD raw materials to premium blockers and stabilizers by acquiring CANDOR Bioscience

January 22, 2025

Categories: Healthcare, Corporate, Finance & Investor, Clinical Diagnostics

PrecisionLife appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare

January 8, 2025